Shield Therapeutics PLC (STX)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
6.00p
Buy
6.30p
-0.05p (-0.81%)
Prices updated at 24 Jul 2026, 14:56 BST
| Prices minimum 15 mins delay
Prices in GBX
Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company that delivers ACCRUFeR/FeRACCRU (ferric maltol), a differentiated pharmaceutical product, to address the unmet need for patients suffering from iron deficiency, with or wit ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| 6.40p - 6.00p | |
| 12.50p - 4.30p | |
| - | |
| 65.78m | |
| - | |
| 150,000 | |
| 1,283,574 | |
| - | |
| 2,681,125.62 | |
| 2.54 | |
| 1,067.84m | |
| GB00BYV81293 | |
| -0.02 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.